mpns: a changing treatment landscape
Published 3 years ago • 62 plays • Length 2:55Download video MP4
Download video MP3
Similar videos
-
1:43
the changing treatment landscape of pnh: novel agents and combinations
-
4:22
accelerated-phase mpns: pathophysiology, treatment approaches and ongoing clinical trials
-
1:14
an overview of the current and future treatment landscape for mpns
-
1:54
current treatment landscape in classical mpns
-
0:56
the role of navtemadlin in the mpn treatment landscape
-
1:23
insights into the management and treatment of accelerated/blast-phase mpns
-
1:26
the future of jak inhibition for mpns
-
55:34
clinical trial updates for physicians
-
28:08
dr. gaby hobbs, md: diagnosis and initial treatment options for et, pv & mf
-
3:12
diagnosed early in life with polycythemia vera: todd’s mpn story
-
1:51
checkpoint inhibition in the treatment of mpns
-
2:43
the management of advanced phase mpns
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
1:49
advances in the science and treatment of mpns
-
1:22
the future of mpn treatment: moving towards combination therapies
-
0:45
non-pharmaceutical interventions for patients with mpns and other hematological malignancies
-
2:03
the current landscape of treatment for bpdcn
-
2:21
the potential applications for immunotherapy in mpns
-
2:28
how to approach the treatment of younger patients with mpn
-
1:31
novel treatment agents and how they're changing the mpn field
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023